A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation

NCT02823470 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated early due to slow recruitment of patients.

Conditions

Cystic Fibrosis

Interventions

DRUG: LUM/IVA
DEVICE: activated smart device
DEVICE: de-activated smart device

Sponsor

Vertex Pharmaceuticals Incorporated